Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Favipiravir in Mild & Moderate COVID-19 in Nepal
NCT04694612Phase 3Unknown
- Sponsor
- Nepal Health Research Council
- Start
- Jan 2021
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of favipiravir in coronavirus disease 2019 (COVID-19), sponsored by Nepal Health Research Council. Status: unknown.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04694612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04694612.